PubMed:8842705 / 444-653 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":209},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":209},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T28","span":{"begin":95,"end":107},"obj":"FMAID:197276"},{"id":"_T29","span":{"begin":95,"end":107},"obj":"FMAID:82737"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response."}

{"project":"uniprot-human","denotations":[{"id":"T2","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P07204"},{"id":"T6","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q14264"},{"id":"T10","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P60507"},{"id":"T14","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P60608"},{"id":"T18","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P60508"},{"id":"T22","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q902F9"},{"id":"T26","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q9NX77"},{"id":"T30","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/O42043"},{"id":"T34","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/O71037"},{"id":"T38","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P61565"},{"id":"T42","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P61566"},{"id":"T46","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P61570"},{"id":"T50","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q69384"},{"id":"T54","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P61567"},{"id":"T58","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q902F8"},{"id":"T62","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q9UKH3"},{"id":"T66","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P60509"},{"id":"T70","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P61550"},{"id":"T74","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q9UQF0"},{"id":"T78","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q9N2J8"},{"id":"T82","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q9N2K0"}],"text":"In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response."}

{"project":"uniprot-mouse","denotations":[{"id":"T2","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/P15306"},{"id":"T6","span":{"begin":55,"end":57},"obj":"http://www.uniprot.org/uniprot/Q811M9"}],"text":"In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response."}

{"project":"GO-BP","denotations":[{"id":"T10","span":{"begin":95,"end":117},"obj":"http://purl.obolibrary.org/obo/GO_0016051"},{"id":"T11","span":{"begin":108,"end":117},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response."}